Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPAIN-trial
2024-514020-16-00Phase 4Authorised
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Post-craniotomy headache (PCH) comparing Esketamine with Placebo (sodium chloride) (2 arms). Primary endpoint: Total postoperative opioid consumption at day 7. Planned start Dec 2024; status: authorised.
02
Drugs
esketamine
03
Conditions
Post-craniotomy headache (PCH)
Beyond the preview
Go deeper on 2024-514020-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514020-16-00.